Tag:
doctors
Latest Headlines
Latest Headlines
U.K. watchdog may turn to social media for side-effect reports
Would docs tweet more adverse-event reports? The U.K.'s medicines regulator may soon find out. The Medicines and Healthcare products Regulatory Agency is considering opening up its side-effects
Industry funding for CME falls 31% to $830M
Last week, updated data on pharma's payments to doctors hinted at some pullback. Some physicians apparently are backing away from doing pharma work because of increased scrutiny of those
Top drugmakers spent $220M on doctor-speakers
For those of you who like to slice and dice info on drugmakers' financial ties to doctors, the pool of data just got a lot bigger. ProPublica has compiled the numbers on 12 pharma companies' payments
FT: Pharma payments to U.S. docs hit $150M
A dozen drugmakers have paid 165,000 U.S. doctors nearly $150 million so far this year, the Financial Times finds; last year's total was $437 million for 262,000 doctors. Report
Docs like pharma dinners--with a few caveats
Marketing managers, listen up: what would bring a doctor out for a pharma-sponsored dinner meeting? Info on multiple sclerosis treatment, for one. Updates on new anti-clotting drugs, for another.
Lilly adds food, travel to doc-payment report
Eli Lilly ( $LLY ) expanded its disclosure on payments to doctors and healthcare groups, adding food and other non-cash gifts to the mix. In its latest quarterly payments report, mandated by a
Harvard docs punished for undisclosed pharma ties
Three Harvard Medical School psychiatrists who made headlines for their ties to the pharma industry are now being sanctioned by the school and its affiliated Massachusetts General Hospital. According
Is pharma's rep among doctors on the upswing?
Drugmakers may be heartened to hear that doctors' perceptions of the pharmaceutical industry have actually improved this year, the first time since 2004 that their positive feelings grew. Consumers,
U.S. Army reopens doc payment investigation
Now that a $25 million settlement with Novo Nordisk has closed, the U.S. Army has restarted its probe of improper doctor payments at Fort Sam Houston in San Antonio. The Army is keeping its mouth
Senate mulls bill to keep pharma documents unsealed
The U.S. Senate is looking at spreading the sunshine. Now that lawmakers have pushed through a mandate for drugmakers to disclose payments to doctors, they're considering the "Sunshine in Litigation
